{
    "organizations": [],
    "uuid": "ef0b690f92b13d79ac9d4ae5cea9e1a0d8c39cc4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-actinium-pharmaceuticals-amends-pr/brief-actinium-pharmaceuticals-amends-pricing-terms-of-rights-offering-idUSASB0C7G9",
    "ord_in_thread": 0,
    "title": "BRIEF-Actinium Pharmaceuticals Amends Pricing Terms Of Rights Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 26, 2018 / 3:17 PM / Updated 4 minutes ago BRIEF-Actinium Pharmaceuticals Amends Pricing Terms Of Rights Offering Reuters Staff 1 Min Read Feb 26 (Reuters) - Actinium Pharmaceuticals Inc: * ACTINIUM PHARMACEUTICALS REITERATES PREVIOUSLY ANNOUNCED EXPIRATION DATE OF MARCH 2, 2018 AT 5:00 PM ET AND AMENDMENT TO PRICING TERMS OF ITS RIGHTS OFFERING * SAYS ‍PRICING OF UNITS AMENDED TO $0.50/UNIT WITH CORRESPONDING AMENDMENTS TO WARRANT EXERCISE PRICES​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-26T17:15:00.000+02:00",
    "crawled": "2018-02-26T17:26:06.053+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "amends",
        "pricing",
        "term",
        "right",
        "offering",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "actinium",
        "pharmaceutical",
        "inc",
        "actinium",
        "pharmaceutical",
        "reiterates",
        "previously",
        "announced",
        "expiration",
        "date",
        "march",
        "pm",
        "et",
        "amendment",
        "pricing",
        "term",
        "right",
        "offering",
        "say",
        "unit",
        "amended",
        "corresponding",
        "amendment",
        "warrant",
        "exercise",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}